Nettoinventarwert (NAV)
| 14.76 CHF | 0.34 CHF | 2.38 % |
|---|
| Vortag | 14.42 CHF | Datum | 05.10.2026 |
ETP on Solactive Longevity NTR Index CHF Kurs - 1 Jahr
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 185.82% | |
| 21Shares Stacks ETP | CH1258969042 | 154.88% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 130.82% | |
| 21Shares Arbitrum ETP | CH1304867463 | 115.43% | |
| 21Shares Injective Staking ETP | CH1360612134 | 84.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 153.83% | |
| 21Shares Raydium ETP | CH1480821391 | 121.52% | |
| 21Shares Injective Staking ETP | CH1360612134 | 115.09% | |
| 21Shares Uniswap ETP | CH1135202096 | 100.26% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 83.24% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 93.41% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 88.97% | |
| 21Shares Raydium ETP | CH1480821391 | 31.07% | |
| 21Shares Uniswap ETP | CH1135202096 | 21.59% | |
| 21Shares Injective Staking ETP | CH1360612134 | 17.79% |
Fundamentaldaten
| Valor | |
| ISIN | CH1292088973 |
| Emittent | LEONTEQ SECURITIES |
| Aufgelegt in | Switzerland |
| Auflagedatum | 03.05.2024 |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | CHF |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 13.10.2026 |
Anlagepolitik
So investiert der ETP on Solactive Longevity NTR Index CHF: Objective of the product is to provide the investor with a specified entitlement according to predefined conditions. This product allows the investor to participate in price movements of the Underlying and is therefore – in terms of risk – comparable to a direct investment in the Underlying. On the Redemption Date, the Investor will receive a Cash Settlement in the Settlement Currency.